Ceribell, inc. CBLL.US Overview
CBLL AI Analysis & Strategy
Browsing restrictions can be lifted for a fee.
CBLL Current Performance
-3.97%
Ceribell, inc.
-1.83%
Avg of Sector
-0.40%
S&P500
CBLL Key Information
CBLL Revenue by Segments
Browsing restrictions can be lifted for a fee.
CBLL Net Income
Browsing restrictions can be lifted for a fee.
CBLL Cash Flow
Browsing restrictions can be lifted for a fee.
CBLL Profit Margin
Browsing restrictions can be lifted for a fee.
CBLL PE Ratio River
Browsing restrictions can be lifted for a fee.
CBLL Financial Forecast
Browsing restrictions can be lifted for a fee.
CBLL Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2024Q4 | |||||||
| 2024Q3 | |||||||
| 2024Q2 | |||||||
| 2024Q1 |
CBLL Profile
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.
Price of CBLL
CBLL FAQ
When is CBLL's latest earnings report released?
The most recent financial report for Ceribell, inc. (CBLL) covers the period of 2025Q1 and was published on 2025/03/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating CBLL's short-term business performance and financial health. For the latest updates on CBLL's earnings releases, visit this page regularly.
What is the operating profit of CBLL?
According to the latest financial report, Ceribell, inc. (CBLL) reported an Operating Profit of -14.21M with an Operating Margin of -69.33% this period, representing a decline of 68.25% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is CBLL's revenue growth?
In the latest financial report, Ceribell, inc. (CBLL) announced revenue of 20.49M, with a Year-Over-Year growth rate of 37.92%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much debt does CBLL have?
As of the end of the reporting period, Ceribell, inc. (CBLL) had total debt of 21.76M, with a debt ratio of 0.1. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
How much cash does CBLL have?
At the end of the period, Ceribell, inc. (CBLL) held Total Cash and Cash Equivalents of 153.36M, accounting for 0.72 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does CBLL go with three margins increasing?
In the latest report, Ceribell, inc. (CBLL) did not achieve the “three margins increasing” benchmark, with a gross margin of 87.9%%, operating margin of -69.33%%, and net margin of -62.4%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess CBLL's profit trajectory and future growth potential.
Is CBLL's EPS continuing to grow?
According to the past four quarterly reports, Ceribell, inc. (CBLL)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.36. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of CBLL?
Ceribell, inc. (CBLL)'s Free Cash Flow (FCF) for the period is -11.55M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 29.68% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
What are the PEG ratio and PE ratio of CBLL?
The latest valuation data shows Ceribell, inc. (CBLL) has a Price-To-Earnings (PE) ratio of -13.49 and a Price/Earnings-To-Growth (PEG) ratio of 1.35. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.